JLB & Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23.2M | Sell |
64,097
-878
| -1% | -$301K | 3.1% | 8 |
|
|
2026
Q1 | $22.9M | Sell |
64,975
-977
| -1% | -$348K | 3.28% | 8 |
|
|
2025
Q4 | $21.6M | Sell |
65,952
-1,140
| -2% | -$362K | 2.91% | 11 |
|
|
2025
Q3 | $18.9M | Buy |
67,092
+737
| +1% | +$214K | 2.49% | 15 |
|
|
2025
Q2 | $18.5M | Sell |
66,355
-831
| -1% | -$235K | 2.58% | 15 |
|
|
2025
Q1 | $20.9M | Sell |
67,186
-725
| -1% | -$214K | 2.92% | 12 |
|
|
2024
Q4 | $17.7M | Sell |
67,911
-1,028
| -1% | -$305K | 2.4% | 18 |
|
|
2024
Q3 | $22.2M | Sell |
68,939
-448
| -0.6% | -$147K | 2.86% | 11 |
|
|
2024
Q2 | $21.7M | Sell |
69,387
-256
| -0.4% | -$75.2K | 2.93% | 9 |
|
|
2024
Q1 | $19.8M | Sell |
69,643
-503
| -0.7% | -$147K | 2.63% | 12 |
|
|
2023
Q4 | $20.2M | Sell |
70,146
-35
| -0% | -$9.54K | 2.9% | 9 |
|
|
2023
Q3 | $18.9M | Sell |
70,181
-3,974
| -5% | -$992K | 2.96% | 11 |
|
|
2023
Q2 | $16.5M | Buy |
74,155
+60
| +0.1% | +$13.9K | 2.35% | 19 |
|
|
2023
Q1 | $17.9M | Buy |
74,095
+808
| +1% | +$198K | 2.7% | 14 |
|
|
2022
Q4 | $19.2M | Sell |
73,287
-368
| -0.5% | -$98.6K | 3.07% | 8 |
|
|
2022
Q3 | $16.6M | Sell |
73,655
-100
| -0.1% | -$24.2K | 2.94% | 8 |
|
|
2022
Q2 | $17.9M | Sell |
73,755
-157
| -0.2% | -$38.5K | 3.06% | 7 |
|
|
2022
Q1 | $17.9M | Buy |
73,912
+1,271
| +2% | +$292K | 2.67% | 12 |
|
|
2021
Q4 | $16.3M | Buy |
72,641
+2,756
| +4% | +$582K | 2.32% | 18 |
|
|
2021
Q3 | $14.9M | Buy |
69,885
+1,935
| +3% | +$445K | 2.36% | 18 |
|
|
2021
Q2 | $16.6M | Buy |
67,950
+197
| +0.3% | +$48.5K | 2.58% | 14 |
|
|
2021
Q1 | $16.9M | Sell |
67,753
-293
| -0.4% | -$69.9K | 2.77% | 12 |
|
|
2020
Q4 | $15.6M | Buy |
68,046
+222
| +0.3% | +$51.2K | 2.6% | 14 |
|
|
2020
Q3 | $17.2M | Sell |
67,824
-1,147
| -2% | -$284K | 3.17% | 7 |
|
|
2020
Q2 | $16.3M | Sell |
68,971
-1,259
| -2% | -$287K | 3.25% | 6 |
|
|
2020
Q1 | $14.2M | Sell |
70,230
-1,730
| -2% | -$378K | 3.38% | 5 |
|
|
2019
Q4 | $17.3M | Buy |
71,960
+1,853
| +3% | +$408K | 3.19% | 6 |
|
|
2019
Q3 | $13.6M | Buy |
70,107
+757
| +1% | +$145K | 2.69% | 14 |
|
|
2019
Q2 | $12.8M | Buy |
69,350
+1,417
| +2% | +$254K | 2.58% | 15 |
|
|
2019
Q1 | $12.9M | Buy |
67,933
+1,039
| +2% | +$198K | 2.72% | 12 |
|
|
2018
Q4 | $13M | Buy |
66,894
+77
| +0.1% | +$15K | 3.17% | 5 |
|
|
2018
Q3 | $13.8M | Sell |
66,817
-3,593
| -5% | -$708K | 2.97% | 8 |
|
|
2018
Q2 | $13M | Buy |
70,410
+6,544
| +10% | +$1.16M | 2.77% | 11 |
|
|
2018
Q1 | $10.9M | Buy |
63,866
+973
| +2% | +$179K | 2.34% | 16 |
|
|
2017
Q4 | $10.9M | Buy |
62,893
+4,113
| +7% | +$728K | 2.38% | 17 |
|
|
2017
Q3 | $11M | Buy |
58,780
+1,726
| +3% | +$306K | 2.68% | 12 |
|
|
2017
Q2 | $9.83M | Buy |
+57,054
| New | +$9.28M | 2.49% | 15 |
|
|
2016
Q4 | $7.79M | Buy |
53,298
+1,178
| +2% | +$177K | 2.11% | 23 |
|
|
2016
Q3 | $8.69M | Buy |
+52,120
| New | +$8.81M | 2.4% | 17 |
|
|
2016
Q2 | – | Sell |
-54,831
| Closed | -$8.9M | – | 72 |
|
|
2016
Q1 | $8.9M | Buy |
54,831
+7,047
| +15% | +$1.05M | 2.27% | 20 |
|
|
2015
Q4 | $7.76M | Buy |
47,784
+538
| +1% | +$84.6K | 2.4% | 17 |
|
|
2015
Q3 | $6.54M | Buy |
47,246
+1,525
| +3% | +$240K | 2.11% | 22 |
|
|
2015
Q2 | $7.02M | Buy |
45,721
+1,489
| +3% | +$239K | 2.17% | 20 |
|
|
2015
Q1 | $7.07M | Buy |
44,232
+2,460
| +6% | +$387K | 2.21% | 19 |
|
|
2014
Q4 | $6.65M | Sell |
41,772
-273
| -0.6% | -$42.5K | 2.21% | 20 |
|
|
2014
Q3 | $5.91M | Buy |
42,045
+1,127
| +3% | +$147K | 2.12% | 18 |
|
|
2014
Q2 | $4.84M | Buy |
40,918
+4,887
| +14% | +$566K | 1.76% | 26 |
|
|
2014
Q1 | $4.44M | Buy |
36,031
+2,017
| +6% | +$245K | 1.66% | 27 |
|
|
2013
Q4 | $3.88M | Buy |
34,014
+596
| +2% | +$67.8K | 1.48% | 29 |
|
|
2013
Q3 | $3.74M | Buy |
33,418
+5,139
| +18% | +$557K | 1.58% | 30 |
|
|
2013
Q2 | $2.79M | Buy |
+28,279
| New | +$2.93M | 1.27% | 36 |
|
Other funds holding AMGN
JLB & Associates's AMGN Position: Q2 2026 in Review
JLB & Associates reduced its Amgen (AMGN) stake by 1.4% in Q2 2026, selling an estimated $301K and leaving 64,097 shares worth $23.2M. The position accounts for 3.1% of the portfolio, ranked #8.
JLB & Associates first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- JLB & Associates held 64,097 shares of Amgen worth $23.2M as of Q2 2026.
- JLB & Associates sold 878 Amgen shares in Q2 2026, an estimated $301K.
- Amgen made up 3.1% of JLB & Associates's portfolio in Q2 2026, its #8 holding.
- JLB & Associates first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on JLB & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.